Literature DB >> 24332722

The impact of age on the epidemiology of atrial fibrillation hospitalizations.

Sahar Naderi1, Yun Wang2, Amy L Miller3, Fátima Rodriguez4, Mina K Chung1, Martha J Radford5, Joanne M Foody6.   

Abstract

BACKGROUND: Given that 4 million individuals in the United States have atrial fibrillation, understanding the epidemiology of this disease is crucial. We sought to identify and characterize the impact of age on national atrial fibrillation hospitalization patterns.
METHODS: The study sample was drawn from the 2009-2010 Nationwide Inpatient Sample. Patients hospitalized with a principal International Classification of Diseases, 9th Revision discharge diagnosis of atrial fibrillation were included. Patients were categorized as "older" (≥65 years) or "younger" (<65 years) for the purposes of analysis. The outcomes measured included hospitalization rate, length of stay, in-hospital mortality, and discharge status.
RESULTS: We identified 192,846 atrial fibrillation hospitalizations. There was significant geographic variation in hospitalizations for both younger and older age groups. States with high hospitalizations differed from those states known to have high stroke mortality. Younger patients (33% of the sample) were more likely to be obese (21% vs 8%, P < .001) and to use alcohol (8% vs 2%, P < .001). Older patients were more likely to have kidney disease (14% vs 7%, P < .001). Both age groups had high rates of hypertension and diabetes. Older patients had higher in-hospital mortality and were more likely to be discharged to a nursing or intermediate care facility.
CONCLUSIONS: Younger patients account for a substantial minority of atrial fibrillation hospitalizations in contemporary practice. Younger patients are healthier, with a different distribution of risk factors, than older patients who have higher associated morbidity and mortality.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Age; Atrial fibrillation; Epidemiology

Mesh:

Year:  2013        PMID: 24332722      PMCID: PMC4436031          DOI: 10.1016/j.amjmed.2013.10.005

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  25 in total

1.  National and regional trends in heart failure hospitalization and mortality rates for Medicare beneficiaries, 1998-2008.

Authors:  Jersey Chen; Sharon-Lise T Normand; Yun Wang; Harlan M Krumholz
Journal:  JAMA       Date:  2011-10-19       Impact factor: 56.272

2.  Risk of bleeding with 2 doses of dabigatran compared with warfarin in older and younger patients with atrial fibrillation: an analysis of the randomized evaluation of long-term anticoagulant therapy (RE-LY) trial.

Authors:  John W Eikelboom; Lars Wallentin; Stuart J Connolly; Mike Ezekowitz; Jeff S Healey; Jonas Oldgren; Sean Yang; Marco Alings; Scott Kaatz; Stefan H Hohnloser; Hans-Christoph Diener; Maria Grazia Franzosi; Kurt Huber; Paul Reilly; Jeanne Varrone; Salim Yusuf
Journal:  Circulation       Date:  2011-05-16       Impact factor: 29.690

Review 3.  Risk factors for atrial fibrillation: Not always severe heart disease, not always so 'lonely'.

Authors:  Marcin Rosiak; Michał Dziuba; Michał Chudzik; Iwona Cygankiewicz; Karol Bartczak; Jarosław Drozdz; Jerzy Krzysztof Wranicz
Journal:  Cardiol J       Date:  2010       Impact factor: 2.737

4.  Unmet health needs of uninsured adults in the United States.

Authors:  J Z Ayanian; J S Weissman; E C Schneider; J A Ginsburg; A M Zaslavsky
Journal:  JAMA       Date:  2000-10-25       Impact factor: 56.272

Review 5.  Genetics of atrial fibrillation: implications for future research directions and personalized medicine.

Authors:  Steven A Lubitz; Cevher Ozcan; Jared W Magnani; Stefan Kääb; Emelia J Benjamin; Patrick T Ellinor
Journal:  Circ Arrhythm Electrophysiol       Date:  2010-06

6.  Estimation of total incremental health care costs in patients with atrial fibrillation in the United States.

Authors:  Michael H Kim; Stephen S Johnston; Bong-Chul Chu; Mehul R Dalal; Kathy L Schulman
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2011-05-03

7.  Prevention of atrial fibrillation: report from a national heart, lung, and blood institute workshop.

Authors:  Emelia J Benjamin; Peng-Sheng Chen; Diane E Bild; Alice M Mascette; Christine M Albert; Alvaro Alonso; Hugh Calkins; Stuart J Connolly; Anne B Curtis; Dawood Darbar; Patrick T Ellinor; Alan S Go; Nora F Goldschlager; Susan R Heckbert; José Jalife; Charles R Kerr; Daniel Levy; Donald M Lloyd-Jones; Barry M Massie; Stanley Nattel; Jeffrey E Olgin; Douglas L Packer; Sunny S Po; Teresa S M Tsang; David R Van Wagoner; Albert L Waldo; D George Wyse
Journal:  Circulation       Date:  2009-02-03       Impact factor: 29.690

8.  Dabigatran versus warfarin in patients with atrial fibrillation.

Authors:  Stuart J Connolly; Michael D Ezekowitz; Salim Yusuf; John Eikelboom; Jonas Oldgren; Amit Parekh; Janice Pogue; Paul A Reilly; Ellison Themeles; Jeanne Varrone; Susan Wang; Marco Alings; Denis Xavier; Jun Zhu; Rafael Diaz; Basil S Lewis; Harald Darius; Hans-Christoph Diener; Campbell D Joyner; Lars Wallentin
Journal:  N Engl J Med       Date:  2009-08-30       Impact factor: 91.245

9.  Hospitalization for congestive heart failure: United States, 2000-2010.

Authors:  Margaret Jean Hall; Shaleah Levant; Carol J DeFrances
Journal:  NCHS Data Brief       Date:  2012-10

10.  Outcomes for mitral valve surgery among Medicare fee-for-service beneficiaries, 1999 to 2008.

Authors:  John A Dodson; Yun Wang; Mayur M Desai; Jose Augusto Barreto-Filho; Lissa Sugeng; Sabet W Hashim; Harlan M Krumholz
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2012-05-10
View more
  12 in total

1.  The AFFORD clinical decision aid to identify emergency department patients with atrial fibrillation at low risk for 30-day adverse events.

Authors:  Tyler W Barrett; Alan B Storrow; Cathy A Jenkins; Robert L Abraham; Dandan Liu; Karen F Miller; Kelly M Moser; Stephan Russ; Dan M Roden; Frank E Harrell; Dawood Darbar
Journal:  Am J Cardiol       Date:  2015-01-06       Impact factor: 2.778

Review 2.  Atrial Fibrillation: Epidemiology, Pathophysiology, and Clinical Outcomes.

Authors:  Laila Staerk; Jason A Sherer; Darae Ko; Emelia J Benjamin; Robert H Helm
Journal:  Circ Res       Date:  2017-04-28       Impact factor: 17.367

3.  Central Sleep-disordered Breathing Predicts Incident Atrial Fibrillation in Older Men.

Authors:  Anna M May; Terri Blackwell; Peter H Stone; Katie L Stone; Peggy M Cawthon; William H Sauer; Paul D Varosy; Susan Redline; Reena Mehra
Journal:  Am J Respir Crit Care Med       Date:  2016-04-01       Impact factor: 21.405

4.  Validation of the Risk Estimator Decision Aid for Atrial Fibrillation (RED-AF) for predicting 30-day adverse events in emergency department patients with atrial fibrillation.

Authors:  Tyler W Barrett; Cathy A Jenkins; Wesley H Self
Journal:  Ann Emerg Med       Date:  2014-09-20       Impact factor: 5.721

5.  European Heart Rhythm Association (EHRA)/Heart Rhythm Society (HRS)/Asia Pacific Heart Rhythm Society (APHRS)/Latin American Heart Rhythm Society (LAHRS) expert consensus on risk assessment in cardiac arrhythmias: use the right tool for the right outcome, in the right population.

Authors:  Jens Cosedis Nielsen; Yenn-Jiang Lin; Marcio Jansen de Oliveira Figueiredo; Alireza Sepehri Shamloo; Alberto Alfie; Serge Boveda; Nikolaos Dagres; Dario Di Toro; Lee L Eckhardt; Kenneth Ellenbogen; Carina Hardy; Takanori Ikeda; Aparna Jaswal; Elizabeth Kaufman; Andrew Krahn; Kengo Kusano; Valentina Kutyifa; Han S Lim; Gregory Y H Lip; Santiago Nava-Townsend; Hui-Nam Pak; Gerardo Rodríguez Diez; William Sauer; Anil Saxena; Jesper Hastrup Svendsen; Diego Vanegas; Marmar Vaseghi; Arthur Wilde; T Jared Bunch; Alfred E Buxton; Gonzalo Calvimontes; Tze-Fan Chao; Lars Eckardt; Heidi Estner; Anne M Gillis; Rodrigo Isa; Josef Kautzner; Philippe Maury; Joshua D Moss; Gi-Byung Nam; Brian Olshansky; Luis Fernando Pava Molano; Mauricio Pimentel; Mukund Prabhu; Wendy S Tzou; Philipp Sommer; Janice Swampillai; Alejandro Vidal; Thomas Deneke; Gerhard Hindricks; Christophe Leclercq
Journal:  Europace       Date:  2020-08-01       Impact factor: 5.214

6.  Atrial fibrillation in immigrants under the age of 45 y in Sweden.

Authors:  Per Wändell; Axel C Carlsson; Xinjun Li; Danijela Gasevic; Johan Ärnlöv; Martin J Holzmann; Jan Sundquist; Kristina Sundquist
Journal:  Int Health       Date:  2019-05-01       Impact factor: 2.473

7.  Effects of ivabradine on cardiac electrophysiology in dogs with age-related atrial fibrillation.

Authors:  Yao-Dong Li; Yu-Tong Ji; Xian-Hui Zhou; Tao Jiang; Yi-fan Hong; Jin-Xin Li; Qiang Xing; Jian Xiong; Yueerguli Yusufuaji; Bao-Peng Tang
Journal:  Med Sci Monit       Date:  2015-05-16

8.  Geographical variation and clustering are found in atrial fibrillation beyond socioeconomic differences: a Danish cohort study, 1987-2015.

Authors:  Kirstine Wodschow; Kristine Bihrmann; Mogens Lytken Larsen; Gunnar Gislason; Annette Kjær Ersbøll
Journal:  Int J Health Geogr       Date:  2021-03-01       Impact factor: 3.918

Review 9.  Cost-Effectiveness of Cardiac Radiosurgery for Atrial Fibrillation: Implications for Reducing Health Care Morbidity, Utilization, and Costs.

Authors:  Nikhilesh Bhatt; Mintu Turakhia; Thomas J Fogarty
Journal:  Cureus       Date:  2016-08-01

10.  Analysis of Pulmonary Vein Antrums Motion with Cardiac Contraction Using Dual-Source Computed Tomography.

Authors:  Houda Bahig; Jacques de Guise; Toni Vu; Carl Chartrand-Lefebvre; Danis Blais; Martin Lebeau; Nhu-Tram Nguyen; David Roberge
Journal:  Cureus       Date:  2016-07-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.